These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2609645)
1. [The effect of myelopeptides on the persistence of tick-borne encephalitis virus in monkeys]. Pogodina VV; Levina LS; Mikhaĭlova AA; Sergeev IuO; Frolova MP; Roĭkhel' BM; Fokina GI Vopr Virusol; 1989; 34(5):580-5. PubMed ID: 2609645 [TBL] [Abstract][Full Text] [Related]
2. Exploring of primate models of tick-borne flaviviruses infection for evaluation of vaccines and drugs efficacy. Pripuzova NS; Gmyl LV; Romanova LIu; Tereshkina NV; Rogova YV; Terekhina LL; Kozlovskaya LI; Vorovitch MF; Grishina KG; Timofeev AV; Karganova GG PLoS One; 2013; 8(4):e61094. PubMed ID: 23585873 [TBL] [Abstract][Full Text] [Related]
3. [Efficiency of coadministration of immunomodulators and vaccine in an experiment on tick-borne encephalitis]. Barinskiĭ IF; Lazarenko AA; Alimbarova LM; Davydova AA Vopr Virusol; 2011; 56(4):45-7. PubMed ID: 21899071 [TBL] [Abstract][Full Text] [Related]
4. [Effect of gentamycin on persistence of tick-borne encephalitis]. Pogodina VV; Malenko GV; Karmysheva VIa; Frolova MP Vopr Virusol; 1999; 44(1):35-9. PubMed ID: 10190241 [TBL] [Abstract][Full Text] [Related]
5. [Immunologic mechanisms of preventing persistence of tick-borne encephalitis virus in mice]. Khozinskiĭ VV; Semenov BF Vopr Virusol; 1989; 34(5):585-90. PubMed ID: 2532810 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of tick-borne encephalitis DNA vaccines in monkeys. Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091 [TBL] [Abstract][Full Text] [Related]
7. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge. Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605 [TBL] [Abstract][Full Text] [Related]
8. Persistence of tick-borne encephalitis virus in monkeys. VII. Some features of the immune response. Pogodina VV; Bochkova NG; Levina LS Acta Virol; 1984 Sep; 28(5):407-15. PubMed ID: 6151355 [TBL] [Abstract][Full Text] [Related]
13. [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm]. Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP; Gorbunov MA; Pavlova LI; Bektimirov TA Vopr Virusol; 1996; 41(5):221-4. PubMed ID: 8967069 [TBL] [Abstract][Full Text] [Related]
14. [Use of inbred mice for assessing the neurovirulence of strains of the tick-borne encephalitis virus complex and the immunogenicity of a concentrated tick-borne encephalitis vaccine]. Kan GA; Borsuk EA; Vorob'eva MS Vopr Virusol; 1982; 27(4):461-4. PubMed ID: 7135927 [TBL] [Abstract][Full Text] [Related]
15. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus. Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616 [TBL] [Abstract][Full Text] [Related]
16. Persistence of tick-borne encephalitis virus in monkeys. I. Features of experimental infection. Pogodina VV; Frolova MP; Malenko GV; Fokina GI; Levina LS; Mamonenko LL; Koreshkova GV; Ralf NM Acta Virol; 1981 Nov; 25(6):337-43. PubMed ID: 6120634 [TBL] [Abstract][Full Text] [Related]
17. [The search for antibiotics not exerting activating action in the persistence of the tick-borne encephalitis virus]. Malenko GV; Pogodina VV Vopr Virusol; 1989; 34(2):197-200. PubMed ID: 2788330 [TBL] [Abstract][Full Text] [Related]
18. [Activating effect of adrenaline, prednisolone and vincristine in the late periods of tick-borne encephalitis virus persistence]. Frolova TV; Pogodina VV Vopr Virusol; 1984; 29(1):103-8. PubMed ID: 6710973 [TBL] [Abstract][Full Text] [Related]
19. Persistence of tic-borne encephalitis virus in monkeys. III. Phenotypes of the persisting virus. Pogodina VV; Levina LS; Fokina GI; Koreshkova GV; Malenko GV; Bochkova NG; Rzhakhova OE Acta Virol; 1981 Nov; 25(6):352-60. PubMed ID: 6120636 [TBL] [Abstract][Full Text] [Related]
20. Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis. Pripuzova NS; Tereshkina NV; Gmyl LV; Dzhivanyan TI; Rumyantsev AA; Romanova LIu; Mustafina AN; Lashkevich VA; Karganova GG J Med Virol; 2009 Oct; 81(10):1777-85. PubMed ID: 19697399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]